Displaying 651 - 660 of 731 results
-
ALERT: MetoprololThis alert highlights recommended actions to reduce the risk in adults of 118.75mg oral metoprolol being administered when metoprolol 11.875mg is prescribed.
-
Safe use of opioids collaborative information for DHB hospitalsInformation document for DHBs about the breakthrough series collaborative on safe use of opioids in hospitals.
-
Safe use of opioids measurement: frequently asked questionsFrequently asked questions about measurement for the safe use of opioids.
-
Opioid implementation packageThis package outlines the next steps and what the options are to make a significant difference in opioid-induced adverse drug events.
-
Acetylcysteine for the treatment of paracetamol overdose and toxicity – 2-bag dosing guidanceNew dosing guidance for acetylcysteine for the treatment of paracetamol overdose and toxicity issued in January 2019.
-
Safety Signal: Changes to the labelling of Bicillin LA®Following international practice, the name and strength description for Bicillin LA® has been changed. The expression of the name will now be benzathine benzylpenicillin tetrahydrate. The expression of product strength will now be 1,200,000 units/2.3
-
#O2TheFix toolkitTools developed by Waitematā DHB to encourage the safer prescribing and the best practice use of oxygen therapy, to reduce harm to patients.
-
Quality improvement toolkitTechniques for reviewing an event and implementing change and improvements.
-
Display of combination product medicines in electronic systemsGuidelines for the display of combination product medicines in electronic systems.
-
ALERT: Transdermal patchesPurpose: To highlight the risks associated with the use of transdermal patches (both from the medicine and the delivery system).